Association of leukocyte telomere length in peripheral blood leukocytes with endometrial cancer risk in Caucasian Americans

Carcinogenesis

Volumn 36, Issue 11, 2015, Pages 1327-1332

  Sun, Yuhui ^a,b   Zhang, Liren ^a   Zhao, Lina ^a   Wu, Xifeng ^a   Gu, Jian ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DNA EXTRACTION; ENDOMETRIUM CANCER; EUROPEAN AMERICAN; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; LEUKOCYTE TELOMERE LENGTH; MEDICAL HISTORY; MIDDLE AGED; PEOPLE BY SMOKING STATUS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; BLOOD; ENDOMETRIUM TUMOR; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MONONUCLEAR CELL; PHYSIOLOGY; TELOMERE; TELOMERE HOMEOSTASIS;

AGED; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; RISK FACTORS; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84984534291     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv133     Document Type: Article

References (50)

1. Howlader, N. et al. (eds). (2014) SEER Cancer Statistics Review, 1975–2011. National Cancer Institute, Bethesda, MD.
2. Dossus, L. et al. (2010) Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer, 127, 442–451.
3. Haidopoulos, D. et al. (2010) Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet. Gynecol. Scand., 89, 1326–1330.
4. Bolton, K.L. et al. (2010) Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat. Genet., 42, 880–884.
5. Spurdle, A.B. et al. (2011) Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat. Genet., 43, 451–454.
6. Blackburn, E.H. et al. (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med., 12, 1133–1138.
7. Blackburn, E.H. (2005) Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett., 579, 859–862.
8. Kurenova, E.V. et al. (1997) Telomere functions. A review. Biochemistry. (Mosc)., 62, 1242–1253.
9. Mathon, N.F. et al. (2001) Cell senescence and cancer. Nat. Rev. Cancer, 1, 203–213.
10. Hahn, W.C. (2003) Role of telomeres and telomerase in the pathogenesis of human cancer. J. Clin. Oncol., 21, 2034–2043.
11. Wentzensen, I.M. et al. (2011) The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 20, 1238–1250.
12. Wu, X. et al. (2003) Telomere dysfunction: a potential cancer predisposition factor. J. Natl. Cancer Inst., 95, 1211–1218.
13. Sanchez-Espiridion, B. et al. (2014) Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Res., 74, 2476–2486.
14. Bau, D.T. et al. (2013) Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer, 119, 4277–4283.
15. Xie, H. et al. (2013) Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma. Cancer, 119, 1885–1891.
16. Weischer, M. et al. (2013) Short telomere length, cancer survival, and cancer risk in 47102 individuals. J. Natl. Cancer Inst., 105, 459–468.
17. Prescott, J. et al. (2010) Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer, 116, 4275–4282.
18. Edge, S.B. et al. (2010) AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. Springer, New York, NY.
19. Xing, J. et al. (2009) Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev. Res. (Phila)., 2, 459–465.
20. Han, L. et al. (2014) Telomere length linking social contexts and cancer risk in Mexican Americans. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5–9. AACR, San Diego, CA.
21. Sun, Y. et al. (2014) Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer, 120, 3040–3048.
22. Jeanclos, E. et al. (2000) Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension, 36, 195–200.
23. Slagboom, P.E. et al. (1994) Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet., 55, 876–882.
24. Chang, J. et al. (2012) Genetic variants in telomere-maintenance genes and bladder cancer risk. PLoS One, 7, e30665.
25. Gu, J. et al. (2011) A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev. Res. (Phila)., 4, 514–521.
26. Bojesen, S.E. et al. (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet., 45, 371–384.
27. Bellido, F. et al. (2013) Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome. Eur. J. Hum. Genet., 21, 511–516.
28. Hou, L. et al. (2012) Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer Lett., 319, 130–135.
29. Gu, J. et al. (2013) Re: short telomere length, cancer survival, and cancer risk in 47 102 individuals. J. Natl. Cancer Inst., 105, 1157.
30. Kyo, S. et al. (1999) Estrogen activates telomerase. Cancer Res., 59, 5917–5921.
31. Misiti, S. et al. (2000) Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol., 20, 3764–3771.
32. Boggess, J.F. et al. (2006) Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines. Gynecol. Oncol., 103, 417–424.
33. Setiawan, V.W. et al. (2013) Type I and II endometrial cancers: have they different risk factors? J. Clin. Oncol., 31, 2607–18.
34. Ali, A.T. (2014) Reproductive factors and the risk of endometrial cancer. Int. J. Gynecol. Cancer, 24, 384–393.
35. Hapangama, D.K. et al. (2008) Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length. Hum. Reprod., 23, 1511–1519.
36. Lee, D.C. et al. (2005) Effect of long-term hormone therapy on telomere length in postmenopausal women. Yonsei Med. J., 46, 471–479.
37. Lin, J. et al. (2011) Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline. Brain Res., 1379, 224–231.
38. Entringer, S. et al. (2015) Maternal estriol concentrations in early gestation predict infant telomere length. J. Clin. Endocrinol. Metab., 100, 267–273.
39. Blasco, M.A. et al. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25–34.
40. Chin, L. et al. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97, 527–538.
41. Hemann, M.T. et al. (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell, 107, 67–77.
42. Nakamura, T.M. et al. (1998) Two modes of survival of fission yeast without telomerase. Science, 282, 493–496.
43. Naito, T. et al. (1998) Circular chromosome formation in a fission yeast mutant defective in two ATM homologues. Nat. Genet., 20, 203–206.
44. Lundblad, V. et al. (1989) A mutant with a defect in telomere elongation leads to senescence in yeast. Cell, 57, 633–643.
45. Hackett, J.A. et al. (2002) Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene, 21, 619–626.
46. Valdes, A.M. et al. (2005) Obesity, cigarette smoking, and telomere length in women. Lancet, 366, 662–664.
47. Schaefer C, et al. The Kaiser Permanente/UCSF genetic epidemiology research study on adult health and aging: Demographic and behavioral influences on telomeres and relationship with all-cause mortality (Abstract/Program 96). Presented at the 62nd Annual Meeting of The American Society of Human Genetics, November 8, 2012. San Francisco, CA.
48. Gadalla, S.M. et al. (2010) Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany, NY), 2, 867–874.
49. Fitzpatrick, A.L. et al. (2007) Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am. J. Epidemiol., 165, 14–21.
50. You, N.C. et al. (2012) A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. Diabetes, 61, 2998–3004.